Suven Pharmaceuticals Limited (SUVENPHAR.NS) NSE
1,078.00
-1.2(-0.11%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Suven Pharmaceuticals Limited
Address
# 8-2-334, SDE Serene Chambers
Hyderabad, 500034
India
Phone
91 40 2354 9414
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1193
First IPO Date
March 09, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Sudhir Kumar Singh | Chief Executive Officer | 0 | 1965 |
| Vivek Sharma | Executive Chairman | 27.27M | N/A |
| Declan Ryan | Chief Commercial Officer | 0 | N/A |
| K. Nagendra Babu | Chief Quality & Compliance Officer | 0 | N/A |
| Vetukuri Venkata Naga Kali Vara Prasada Raju | MD & Director | 0 | N/A |
| Gaurav Narain Bahadur | Chief Human Resources Officer | 0 | 1970 |
| Himanshu Agarwal | Chief Financial Officer | 0 | 1970 |
| Kundan Kumar Jha | Company Secretary & Compliance Officer | 0 | N/A |
| Subba Raju Komaravolu | Chief Strategy Officer | 0 | N/A |
| Sunder Venkatraman | Vice President of Corporate Affairs | 0 | N/A |
| Cyndrella Carvalho | Head of Investor Relations | 0 | N/A |
Description
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
